WMO Education and Training Programme

Bispecific antibodies are engineered antibodies that can simultaneously bind to two different antigens or epitopes. Their binding affinity is a critical parameter that influences their therapeutic efficacy and application in various diseases, including cancer and autoimmune disorders. Creative Biolabs is proud to offer customers one-stop bispecific antibody service, including the design, engineering, manufacturing, and analysis of BsAbs. Equipped with state-of-art platforms, Creative Biolabs is able to help customers to analyze and further develop the BsAbs for therapeutic applications.

Key Concepts Related to Bispecific Antibody Binding Affinity:

1. Definition:

   • Binding affinity refers to the strength of the interaction between an antibody and its target antigen. It is often quantified using the dissociation constant (Kd), where a lower Kd indicates a higher affinity.

2. Importance of Binding Affinity:

   • Efficacy: Higher binding affinity can enhance the therapeutic effectiveness of bispecific antibodies by promoting stronger and more stable interactions with their targets.
   • Specificity: Improved affinity for specific targets can reduce off-target effects, increasing the safety profile of the therapy.

3. Factors Affecting Binding Affinity:

   • Antibody Design: The engineering of the bispecific antibody's structure can significantly influence its binding properties. This includes the choice of antibody format (e.g., full-length antibodies, minibodies, or scFvs).
   • Linker Properties: The linker used to connect the two binding domains can impact flexibility and orientation, affecting how well each domain interacts with its target.
   • Glycosylation: Post-translational modifications, such as glycosylation patterns, can also influence binding affinity and overall stability.